1. Home
  2. News
  3. KPC Pharmaceuticals, Inc.
  4. Indicative Announcement on the Acceptance of New Drug Application
More KPC Pharmaceuticals, Inc. news
KPC Pharmaceuticals, Inc.SSE: 600422

Indicative Announcement on the Acceptance of New Drug Application

Jan 15, 2025 · Issued by KPC Pharmaceuticals, Inc. via Shanghai Stock Exchange

Filed with SSE · Jan 15, 2025 · 2 pages · Chinese

On 6ix: 6ix.com/news/indicative-announcement-on-the-acceptance-of-new-drug-application

Release

Indicative Announcement on the Acceptance of New Drug Application

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

KPC Pharmaceuticals, Inc. on 6ix

Earlier from KPC Pharmaceuticals

  • Announcement on Intended Selection in the National Traditional Chinese Medicine Joint Procurement Alliance's Centralized ProcurementJan 3, 2025
  • Announcement on Resolutions of the 38th Meeting of the 10th Board of DirectorsDec 26, 2024

Later from KPC Pharmaceuticals

  • Announcement on Increasing Idle Self-owned Funds for Investment and Financial BusinessJan 23, 2025
  • Announcement on the Provision of Online Voting Reminder Service for the General MeetingFeb 8, 2025
  • Announcement on Preliminary Earnings Estimate for 2024Feb 11, 2025
  • Announcement on Resolution of the 2nd Extraordinary General Meeting in 2025Feb 14, 2025
  • Announcement on Obtaining Drug Clinical Trial Approval NotificationMar 1, 2025
All KPC Pharmaceuticals news releases↗

Follow KPC Pharmaceuticals into a list and get an email when it puts out news.

Follow KPC Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer